Role of NO/cGMP signaling pathway in cardiac ischemic tolerance of chronically hypoxic rats
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25804095
DOI
10.33549/physiolres.932939
PII: 932939
Knihovny.cz E-zdroje
- MeSH
- chronická nemoc MeSH
- guanosinmonofosfát cyklický fyziologie MeSH
- hypoxie metabolismus MeSH
- ischemická choroba srdeční metabolismus MeSH
- krysa rodu Rattus MeSH
- oxid dusnatý fyziologie MeSH
- potkani Wistar MeSH
- signální transdukce fyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- guanosinmonofosfát cyklický MeSH
- oxid dusnatý MeSH
It has been suggested that increase in acute nitric oxide (NO) or cyclic guanosine monophosphate production may be involved in cardioprotection induced by chronic hypoxia (CH). We studied the effect of NO donor molsidomine and phosphodiesterase type 5 inhibitor sildenafil on myocardial ischemia/reperfusion (I/R) injury in rats adapted to CH. Male Wistar rats were exposed to continuous hypoxia in a normobaric chamber (10 % O(2), 4 weeks). Rats received either saline, molsidomine (10 mg/kg body weight, i.v.) or sildenafil (0.7 mg/kg body weight, i.v.) 30 min before ischemia. Control rats were kept under normoxia and treated in a corresponding manner. Adaptation to CH increased the myocardial ischemic tolerance. Acute treatment with either molsidomine or sildenafil significantly reduced infarct size in normoxic rats and further enhanced cardioprotection induced by CH. However, the cardioprotective effect of CH on I/R injury was not additive to the cardioprotection provided by the drugs.
Citace poskytuje Crossref.org